This content was submitted directly to this Web site by the supplier.

Make better packaging decisions with the all-new Life Science Packaging Materials Playbook

Download the all-new HCP Life Science Packaging Materials Playbook and find out how to consistently select the optimal packaging style and material for your pharma, medicinal devices. Learn More »

Supplier News December 10, 2012

Catalent to supply the newly approved Exelixis CometriqT (Cabozantinib) in the US market

Somerset, NJ, December 7, 2012 – After a 5 year close partnership with Exelixis during which Catalent has provided analytical, clinical trial supply and manufacturing support for COMETRIQ™ (cabozantinib), Catalent welcomes FDA approval for Exelixis’ novel drug for treatment of progressive, metastatic medullary thyroid cancer (MTC). Catalent will now continue to be the exclusive commercial drug supply partner for the 20 mg and 80 mg capsule dose packs in the United States.

Catalent supports pharmaceutical companies, small and large, to help them accelerate their drug development and bring new treatments to improve patient’s lives.”   Said Scott Houlton, President, Development and Clinical Services of Catalent. “We have worked closely with Exelixis over the past several years on COMETRIQ and are delighted to have reached this key milestone.”

“We have been pleased to partner with Catalent over the last 5 years. Catalent has provided high quality service for analytical testing, manufacturing process development and validation.  This partnership has truly helped advance this important product for cancer patients,” said JoAnn Wilson, Vice President, Chemical, Manufacturing and Control at Exelixis, Inc.

All U.S. COMETRIQ capsule manufacturing and packaging operations will be undertaken at Catalent’s 450,000 sq ft, Kansas City, MO facility, which provides a range of fully integrated support services, from formulation development and analytical testing, to clinical supply services as well as clinical and commercial scale manufacturing and packaging of a variety oral dose forms.

E-Book Special Report
Total Cost of Ownership
Sign up to receive timely updates from our editors and download this E-Book Special Report to learn how to calculate the true Total Cost of Ownership (TCO) of your life sciences machinery.


Don't miss intelligence crucial to your job and business!

Click on any newsletter to view a sample. Enter your email address below to sign up!

Each newsletter ranges in frequency from once per month to a few times per month at most.

indicates an article that was submitted directly to this web site by the supplier, and was not handled by the HCP editorial staff. Healthcare Packaging may share your contact information with our sponsors, as detailed in our Privacy Policy. Healthcare Packaging will not share your information with a sponsor whose content you have not reviewed.

Curated By Logo